Tagrisso (Osimertinib) 80mg x 10 Tablets

Tagrisso, containing the active ingredient Osimertinib, is a targeted therapy used for the treatment of non-small cell lung cancer (NSCLC) that is positive for the epidermal growth factor receptor (EGFR) mutation. This innovative medication is designed to inhibit the growth of cancer cells by blocking specific signals that promote tumor growth and survival.